TARO — Taro Pharmaceutical Industries Share News
0.000.00%
HealthcareBalancedMid Cap
- $1.62bn
- $735.77m
- $629.18m
Brief: Taro Announces Resignation Of Chief Financial Officer
Taro Pharma: Jumps on $225 mln share buyback
Brief: Taro Announces Commencement Of Tender Offer To Repurchase Up To $225 Million In Value Of Its Ordinary Shares
Brief: Taro Pharmaceutical Industries Quarterly Sales $160.9 Mln
Brief: Taro Pharmaceutical Industries Says Quarterly Earnings Per Share $1.72
Graphic: Mylan stock boost follows long share struggles for company, generics industry
Graphic: Mylan stock boost follows long share struggles for company, generics industry
Brief: Taro Pharmaceutical Industries Reports Q4 Earnings Per Share Of $1.52
Corrected: (OFFICIAL)-BRIEF-Taro Spokesperson Says Allegations Made In U.S. Lawsuits Without Merit (May 14)
Brief: Taro Pharmaceutical Industries Reports Q3 Sales Of $176.4 Mln
Brief: Taro Pharmaceutical Industries Quarterly Earnings Per Share $1.60
NYSE RESUMED TARO PHARM INDUS
Brief: Taro Pharmaceutical Industries Terminates Agreement With Novabiotics
Brief: Taro Pharmaceutical Industries Reports Q4 EPS $2.17
Brief: Taro Pharmaceutical Industries Posts Q3 Earnings Per Share $0.45
Brief: Taro Pharmaceutical quarterly earnings per share $1.30
Brief: Taro announces joining of CEO
Brief: Taro reports quarterly net income per ordinary share $1.35
Brief: Crescita Therapeutics announces agreement with Taro Pharmaceuticals for Pliaglis